These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 13387155)

  • 1. [Liver function in diabetics treated with N-sulfanilyl-N'-butyl urea].
    DI NOIA V; GALLETTI F; PELLEGRINI R
    Minerva Med; 1956 Sep; 47(73):613-4. PubMed ID: 13387155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modifications of blood glycoproteins in diabetics treated with N-sulfanilyl-N'-butyl urea].
    GALLETTI F; PELLEGRINI R; TOLOMELLI E
    Minerva Med; 1956 Sep; 47(72):582-4. PubMed ID: 13387148
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood protein and lipoprotein picture in diabetics treated with N-sulfanilyl-N'-butyl urea].
    PELLEGRINI R; TOLOMELLI E; VANNINI P
    Minerva Med; 1956 Sep; 47(72):580-1. PubMed ID: 13387147
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood crasis, Mommsen granulations and leukocytic glycogen in diabetics treated with N'-sulfanilyl-N2-n-butyl urea].
    PELLEGRINI R; RUMPIANESI G
    Endocrinol Sci Cost; 1956; 23(4):272-8. PubMed ID: 13404963
    [No Abstract]   [Full Text] [Related]  

  • 5. [N1-sulfanilyl-N2-n-butylcarbamide therapy of diabetes mellitus].
    DALLE COSTE P; KLINGER R
    Minerva Med; 1956 Sep; 47(76):735-43. PubMed ID: 13387177
    [No Abstract]   [Full Text] [Related]  

  • 6. [Case of very severe allergic reaction in peroral management of diabetes mellitus with a sulfonyl urea derivative, N1-sulfanilyl-N2-n-butylcarbamide].
    FELLER J; KUPPER HJ
    Medizinische; 1956 Nov; 1(46):1641-5. PubMed ID: 13386742
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
    BENDFELDT E; OTTO H
    Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophoretic serous patterns (proteins, lipoproteins and glycoproteins) of diabetics during treatment with N-sulfanilyl-N'-butyl urea and N-tolyl-sulfonyl-N'-butyl urea].
    ZAMPA GA
    G Clin Med; 1957 Jan; 38(1):42-57. PubMed ID: 13448420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the electrophoretic behavior of liver glycogen of rats treated with N-sulfanilyl-N'-butyl urea].
    PELLEGRINI R
    Arch Ital Sci Farmacol; 1956 Jul; 6(3):252-4. PubMed ID: 13382480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of N-sulfanilyl-N'-butyl urea and insulin on the blood sugar level in meta-alloxan diabetes in rabbits].
    MOHNIKE G
    Arzneimittelforschung; 1956 Jul; 6(7):388-9. PubMed ID: 13355701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ambulatory treatment of diabetes mellitus with 1-p-amino-benzenesulfonyl 3-n-butyl urea].
    MILANI G; PADOVAN D
    Policlinico Prat; 1956 Sep; 63(37):1305-11. PubMed ID: 13379039
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of N-sulfanilyl-N'-butyl urea on blood sugar level, and phosphate, potassium and sodium level in meta-alloxan diabetes of dogs].
    BIBERGEIL H; MOHNIKE G
    Arzneimittelforschung; 1956 Jul; 6(7):391-3. PubMed ID: 13355703
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new antidiabetic N-sulfanilyl-N'-butyl urea (BZ 55); preliminary results].
    CHAIA J
    Rev Med Moyen Orient; 1957; 14(1):47-50. PubMed ID: 13454198
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of intravenous & oral N-sulfanilyl-N-butyl urea (BZ 55) on blood sugar in diabetics and persons with normal metabolism].
    PFEFFER KH; FUCHS KJ; MICHEL W; FOERDER HK
    Arztl Wochensch; 1957 Mar; 12(12):260-3. PubMed ID: 13410706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of different doses of N-sulfanilyl-N'-butyl urea in rabbits].
    HAGEMANN U; MOHNIKE G
    Arzneimittelforschung; 1956 Jul; 6(7):389-91. PubMed ID: 13355702
    [No Abstract]   [Full Text] [Related]  

  • 17. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)].
    RAUSCH-STROOMANN JG; SAUER H
    Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of N-sulfanilyl-N'-butyl urea in serum, urine and feces].
    HAUSSLER A
    Arzneimittelforschung; 1956 Jul; 6(7):393-4. PubMed ID: 13355704
    [No Abstract]   [Full Text] [Related]  

  • 19. [Findings in the course of antidiabetic treatment with 1-para-aminobenzenesulfonyl-3-N-butyl urea].
    MORSIANI M; SERRAVALLI S
    Arcisp S Anna Ferrara; 1956; 9(4):747-59. PubMed ID: 13382613
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic effects of carbutamide in selected diabetics.
    BASTENIE PA; FRANCKSON JR; DE MEUTTER R; DEMANET TC; CONARD V
    Lancet; 1957 Mar; 272(6967):504-7. PubMed ID: 13407049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.